RA Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
RA Capital Management LLC
CRD #138410
SEC #801-66659
CIK #0001346824
AUM
Employees
Phone617-778-2512
Address111 Huntington Avenue
Boston, MA 02199
Source [IAPD] [EDGAR] [Website]
Total AUM ($M)
604836241202005201120182025
AUM Breakdown Accounts AUM ($M)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 0 0.0
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 2 53.9
By Discretionary
Discretionary 2 53.9
Non-Discretionary 0 0.0
Total 2 53.9
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 53.9
Total 2 53.9
EDGAR Form CIK 2011 - 2025
13F-HR [0001346824]
3 [0001346824]
4 [0001346824]
SC 13D [0001346824]
SC 13G [0001346824]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP Parabilis Medicines Inc [2026-06-18]
RA Capital Management LP Q32 Bio Inc [2026-06-04]
RA Capital Management LP Editas Medicine Inc [2026-06-03]
RA Capital Management LP SANA Biotechnology Inc [2026-05-21]
RA Capital Management LP Atrium Therapeutics Inc [2026-05-15]
RA Capital Management LP Hemab Therapeutics Holdings Inc [2026-05-11]
RA Capital Management LP Altimmune Inc [2026-05-01]
RA Capital Management LP Prelude Therapeutics Inc [2026-04-28]
RA Capital Management LP JATT II Acquisition Corp [2026-04-27]
RA Capital Management LP Onkure Therapeutics Inc [2026-04-07]
View All
Form 3/4/5 Subject 2011 - 2025
Kolchinsky Peter
Shah Rajeev M.
RA Capital Nexus Fund II, L.P.
RA Capital Management LP
RA Capital Nexus Fund III, L.P.
RA Capital Nexus Fund, L.P.
RA Capital Healthcare Fund LP
Climb Bio, Inc.
Septerna, Inc.
Artiva Biotherapeutics, Inc.
ARS Pharmaceuticals, Inc.
Solid Biosciences Inc.
Acrivon Therapeutics, Inc.
Werewolf Therapeutics, Inc.
PepGen Inc.
Sionna Therapeutics, Inc.
LENZ Therapeutics, Inc.
FOG Pharmaceuticals Inc
Vor Biopharma Inc.
Janux Therapeutics, Inc.
Nkarta, Inc.
Bicara Therapeutics Inc.
Acumen Pharmaceuticals, Inc.
Tyra Biosciences, Inc.
RA Capital Nexus Fund IV, L.P.
Adicet Bio, Inc.
Prelude Therapeutics Inc
Mineralys Therapeutics, Inc.
Wave Life Sciences Ltd.
Evommune, Inc.
SpyGlassPharma, Inc.
Cidara Therapeutics, Inc.
Fulcrum Therapeutics, Inc.
89bio, Inc.
Jade Biosciences, Inc.
4D Molecular Therapeutics, Inc.
AN2 Therapeutics, Inc.
iTeos Therapeutics, Inc.
Boundless Bio, Inc.
Icosavax, Inc.
DICE Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Satsuma Pharmaceuticals, Inc.
Enliven Therapeutics, Inc.
Forma Therapeutics Holdings, Inc.
KALA BIO, Inc.
Cytek Biosciences, Inc.
RxSight, Inc.
POINT Biopharma Global Inc.
scPharmaceuticals Inc.
Phathom Pharmaceuticals, Inc.
Orchard Therapeutics plc
Iterum Therapeutics plc
Viridian Therapeutics, Inc.\DE
Rhythm Pharmaceuticals Inc
Vaxcyte, Inc.
Cardiff Oncology, Inc.
PMV Pharmaceuticals, Inc.
Dyne Therapeutics, Inc.
TG Therapeutics Inc
Inhibrx, Inc.
Inozyme Pharma, Inc.
Pandion Therapeutics, Inc.
Akouos, Inc.
Verastem, Inc.
Ra Pharmaceuticals, Inc.
Synthorx, Inc.
Eiger BioPharmaceuticals, Inc.
Arvinas Inc
Eidos Therapeutics, Inc.
Dicerna Pharmaceuticals Inc
KalVista Pharmaceuticals, Inc.
G1 Therapeutics, Inc.
Aclaris Therapeutics, Inc.
Sangamo Therapeutics Inc
Achillion Pharmaceuticals Inc
Derma Sciences Inc
Terms | Privacy | Guide
tony@aum13f.com